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Inappropriate statistical method in a
parallel-group randomized controlled trial
results in unsubstantiated conclusions
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Abstract
The conclusions of Cassani et al. in the January 2015 issue of Nutrition Journal (doi:10.1186/1475-2891-14-5) cannot
be substantiated by the analysis reported nor by the data themselves. The authors ascribed the observed decrease
in inflammatory markers to the components of flaxseed and based their conclusions on within-group comparisons
made between the final and the baseline measurements separately in each arm of the randomized controlled trial.
However, this is an improper approach and the conclusions of the paper are invalid. A correct analysis of the data
shows no such effects.
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Letter to the editor
Randomized controlled trials (RCTs) are vital to estimating
and testing the causal effects of treatments but are only as
good as their design, execution, analysis, and reporting [1].
Rigorous assessment of the effects of foods such as flax-
seed on health outcomes is informative and useful [2].
Hence, Cassani et al.’s [3] description of an RCT of the ef-
fects of flaxseed consumption on body weight and inflam-
mation markers is of interest. Regrettably, however, the
authors draw conclusions that cannot be supported by the
statistical analyses used. Moreover, discrepancies between
the published paper and clinical trial registration raise
questions.
Discrepancies between the published paper and clinical
trial registration
The study registration on ClinicalTrials.gov shows that
the study was completed in 2007 and yet registered in
2014. Moreover, it was designed as a four-arm study, yet
the article reports results from only two groups and offers
neither explanation for nor mention of this discrepancy.
This seems inconsistent with the transparency that clinical
trials registration is designed to promote [4].
Findings
The erroneous nature of the analyses
Cassani et al concluded that “flaxseed added to a weight
loss diet could be an important nutritional strategy to re-
duce inflammation markers such as CRP and TNF- α.”
The statistical analyses offered in the article, however,
were not legitimate tests of the hypotheses in question.
The statistical analyses utilized entailed comparisons of
the outcomes measured at the end of the study with their
pre-intervention levels in each arm separately. The ab-
stract states, “A decrease in inflammatory markers (CRP
and TNF-α) was observed after flaxseed intake (mean de-
crease of 25 % and 46 % for GflaxLC respectively). All
groups also showed improvement in levels of total choles-
terol, LDL-c, uric acid and adiponectin.” The main reason
for conducting an RCT is to provide comparison of an
outcome of interest between two or more experimental
groups or conditions to which subjects have been ran-
domly assigned, such that expected distributions of subject
characteristics before administering the intervention (s)
are identical across randomized groups or conditions [5].
Drawing inferences based on the detected (or not) differ-
ences within a group is improper and can lead to inaccur-
ate and misleading conclusions [6]. As Bland and Altman
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[6] show, this approach can produce type 1 error rates of
up to 0.50 for two-group comparisons when the 0.05
alpha level is used, in other words, a possible inflation of
the false-positive rate by up to an order of magnitude. In-
stead, the analysis should include direct comparison of the
outcome measured at the end of the study between the
groups, usually adjusted for the pre-intervention levels.
By omitting direct between-group comparison of the
outcome variables and by relying on the within-group re-
sults, Cassani et al.’s article misinforms. Specifically, the
article states that a significant decrease in the inflamma-
tory markers CRP and TNF- α was observed only in the
flaxseed group. The authors thus concluded that adding
flaxseed to a weight loss diet could reduce the inflamma-
tion markers CRP and TNF- α. However, no comparison
between the two groups was provided. Thus, the authors
did not answer the question of whether there was a sig-
nificant difference in the outcomes between the two
interventions.
What does a proper analysis of between-group differ-
ences show?
A proper analysis of these data could take several
forms, such as a between-groups t-test (or nonpara-
metric test) on the endpoint data or on the change-
scores, or a between-groups ANCOVA on the endpoint
with baseline values as a covariate, as described by
Allison et al. [7]. All of these involve a test between
the randomized groups.
Cassani et al. should be commended for making their
raw data publically available and for noting this in their
article. We downloaded their data, which were then de-
clared deidentified non-human subjects data by the
University of Alabama at Birmingham’s Institutional
Review Board. We calculated the mean (SD) baseline
and final CRP levels to be respectively 2.77 (2.45) and
1.99 (2.07) in the GriceLC group, and 2.04 (1.48) and
1.51 (0.92) in the GflaxLC group. An ANCOVA of the
final log-transformed CRP levels adjusted for baseline
log-transformed CRP levels suggests no significant dif-
ference between the two groups (p=0.94)1. Data for
TNF-α were available for only 9 (GriceLC) and 11
(GflaxLC) subjects, and contained 2 apparent outliers of
3446 and 1140, which we assumed to correspond to
34.46 and 11.40. Accordingly, we calculated the mean
(SD) baseline and final TNF-α levels to be 25.67 (16.00)
and 22.31 (17.17), respectively, in the GriceLC group,
and 15.46 (16.39) and 7.67 (10.05), respectively, in the
GflaxLC group. An ANCOVA of the final TNF-α levels
adjusted for baseline TNF-α levels suggests no significant
difference between the two groups (p = 0.09)2. Removal of
the outliers also produced nonsignificant results. Alterna-
tively, a rank-sum test of the change-score between the two
groups, for both CRP and TNF-α, produces nonsignificant
results (p = 0.81 and p = 0.82, respectively). Addition-
ally, it should be pointed out that the difference in the
baseline levels between the two groups, and correct-
ness of the data should be assessed, especially given
the small sample size.
Conclusions
Those interested in evidence-based recommendations
need evidence from sound scientific studies, including
soundness of design, execution, analysis, and report-
ing [8] without “spin” [9]. According to the Commit-
tee on Publication Ethics [10], “Journal editors should
consider retracting a publication if…they have clear
evidence that the findings are unreliable [including]…
as a result of …miscalculation or experimental error.”
Cassani et al.’s [3] conclusions are not reliable because
an invalid statistical testing approach was used, and re-
traction should be considered.
Endnotes
1Levene’s test for homogeneity of variance of the
final log-transformed CRP levels was insignificant,
p = 0.18.
2Levene’s test for homogeneity of variance of the final
TNF-α levels was insignificant, p=0.29.
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Discrepancies between the published article and
clinical trial registration records
Dimova and Allison have raised concerns about dis-
crepancies between our published article and the clin-
ical trial registration records. The first relates to the
date of the trial registration. Although this study was
completed in 2007, our group only started to register
our studies in ClinicalTrials.gov in 2014. However, the
trial was registered in the database of brazilian studies
(CAAE - Certificado de Apresentação para Apreciação
Ética - Certificate of Presentation for Ethical Consider-
ation 0161.0.004.000-07) before the work began.
The other discrepancy raised was the absence of two
groups in the published study compared with the four
groups in the clinicaltrials.gov record. This was a result
of suggestions from reviewers.
The reviewer for another journal, to which this article was
submitted before submission to the Nutrition Journal, rec-
ommended that one of the four groups should be not in-
cluded in the article. Differences between the subjects in this
group and the other three groups were given as the reason
for its exclusion. Later, one of the reviewers for the Nutrition
Journal requested that another group should be removed be-
cause of the different intervention used in this group, com-
pared with the two groups in the published article.
Erroneous findings
After reading the article by Bland and Altman [11] and
reviewing the statistical analyses, all authors agree that
this study does not allow us to conclude that there was
decrease in the blood levels of CRP and TNF-alpha that
could be attributed to flaxseed. Initially, the reviewer for
the Nutrition Journal requested that a between-groups t-
test or its non-parametric equivalent should be performed
on our data. This was done for all the data described in
the Tables, which could be noted in the article as the tests
used between-groups mean differences. Unfortunately,
only now it was noticed that the same was not done in the
data shown in the figures (e.g. CRP, TNF-alpha and iso-
prostane). However, we would like to emphasize that this
error was not observed by the Nutrition Journal, which
accepted our article.
We thank Dimova and Allison for commending us for
making our data available to the scientific community.
Also, we were not “disappointed that their treatment had
not produced a significant difference, as well as had not
searched for anything that will have the appearance of
supporting it”, as pointed out by Bland and Altman [11].
Finally, by making our data available to the scientific
community, we hope that the errors in the statistical
analysis will be seen as an honest mistake for which we
sincerely apologize.
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